2MS-16591-46323
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 212 / MD
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Dose 1 — Moderna
-
2021-02-04
Registered in v-safe
-
2021-02-04
Health check-in — day 7, dose 1Feeling: Fair · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-02-10
Survey response — day 14, dose 1MedDRA: Induration, Injection site pruritus, Injection site rash, Injection site warmth, Pruritus, Rash, Skin warm — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Large rash 8 days after vaccine. Hot to touch, hard surface, itchy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-19
-
2021-02-24
Dose 2 — Moderna
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Joint painsAdult check-in
- 2021-03-02
- 2021-03-03
- 2021-04-07
- 2021-08-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Moderna | |
| 2 | 2021-02-24 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-10 | Unsuccessful |
Free text
Release 4 — day 14, dose 1
Symptoms: Large rash 8 days after vaccine. Hot to touch, hard surface, itchy.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Induration | · | · | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ○ |
| SD | Injection site rash | ✓ | ✓ | ○ |
| SD | Injection site warmth | ✓ | ✓ | ○ |
| SD | Pruritus | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Skin warm | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release